Cargando…

Is CC Chemokine Ligand 17 (TARC) Driving Disease Progression in Chronic Obstructive Pulmonary Disease?

Detalles Bibliográficos
Autor principal:	Girkin, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990115/ https://www.ncbi.nlm.nih.gov/pubmed/35133243 http://dx.doi.org/10.1165/rcmb.2021-0518ED

Ejemplares similares

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter
por: Liddiard, Kate, et al.
Publicado: (2006)

Thymus and activation-regulated chemokine (TARC)/CCL17 and IgE are associated with elderly asthmatics
por: Jo, Kyung Mi, et al.
Publicado: (2018)

CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer
por: Chen, Guo, et al.
Publicado: (2014)

Epigenetic regulation of chemokine (CC‐motif) ligand 2 in inflammatory diseases
por: Chen, Yingyi, et al.
Publicado: (2023)

TOF and TARC
Publicado: (2000)

Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis
por: Asahina, Ryota, et al.
Publicado: (2020)

Role of CC-chemokine ligand 2 in gynecological cancer
por: Zhang, Jia-Jia, et al.
Publicado: (2022)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
por: Yamashita, Keita, et al.
Publicado: (2023)

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020)

CCL17/TARC and CCR4 expression in Merkel cell carcinoma
por: Rasheed, Kashif, et al.
Publicado: (2018)

Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2021)

In Chronic Obstructive Pulmonary Disease Progression, Is It Airway Narrowing or Airway Loss?
por: Rizi, Rahim R., et al.
Publicado: (2021)

Memorandum: Completion of the TARC experiment
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1997)

Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2017)

Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2021)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases.
por: Sekerova, Veronika, et al.
Publicado: (2003)

Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)
por: Wang, Ying, et al.
Publicado: (2006)

Members of the TARC Collaboration pictured with their apparatus
Publicado: (1997)

The TARC Experiment at CERN: Modern Alchemy
por: Revol, Jean-Pierre
Publicado: (2017)

Subcorneal Pustular Dermatosis Exhibiting a High Serum TARC/CCL17 Level
por: Ono, Sachiko, et al.
Publicado: (2013)

Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis
por: Goldie, Stephen J., et al.
Publicado: (2018)

CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease
por: Akiyama, Mitsuhiro, et al.
Publicado: (2018)

Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

The association between the CC chemokine ligand 5-28>G and tuberculosis susceptibility
por: Adwan, Marwan Hmoud
Publicado: (2016)

Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7
por: Jaeger, Kathrin, et al.
Publicado: (2019)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
por: Catherine, Julien, et al.
Publicado: (2021)

Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis
por: Radstake, T, et al.
Publicado: (2004)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma
por: Zhou, Wan-Hang, et al.
Publicado: (2022)

What Affects Chronic Obstructive Pulmonary Disease in Korea?
por: Cho, Hae-Wol, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b8s711erjsk5nbrdb8cnbefqs8